Focus Ventures Ltd. (CVE:FCV), a phosphate junior, jumped after signing an off-take Memorandum of Understanding (MOU) with a fertilizer trading company
Sean Mason | July 21, 2017 | SmallCapPower
A potential deal with a fertilizer trading company boosted shares of a phosphate junior Friday. Here’s some small stocks making big moves on Friday, July 21, 2017 (as of 4 pm EST):
Focus Ventures Ltd. (TSXV: FCV) shares rose as much as 13% before ending down 13% at $0.035 on Friday after the phosphate junior announced that it has signed a Memorandum of Understanding (MOU) with an established fertilizer trading company, Keytrade A.G., for the off-take of phosphate rock from the Company’s Bayovar 12 phosphate project in Peru.
As well, shares of Colabor Group Inc. (TSX: GCL) slipped 6% to $0.84 as the distributor of food and related products said its second-quarter sales fell 3.4% to $331.4 million, and added that it has received a termination notice in regards to a supply agreement with the Popeyes Louisiana Kitchen restaurant chain in Ontario, that generated annual sales of more than $40 million.
TearLab Corporation (TSX: TLB), meanwhile, reported that the commercial version of its in-vitro diagnostics testing platform, the TearLab Discovery System, received regulatory clearance from the European Union (EU) and European Free Trade Association (EFTA) member countries. TearLab stock popped 83% to $4.09 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
